Product NDC: | 55289-390 |
Proprietary Name: | Vantin |
Non Proprietary Name: | cefpodoxime proxetil |
Active Ingredient(s): | 200 mg/1 & nbsp; cefpodoxime proxetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-390 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050674 |
Marketing Category: | NDA |
Start Marketing Date: | 19910829 |
Package NDC: | 55289-390-79 |
Package Description: | 1 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-390-79) |
NDC Code | 55289-390-79 |
Proprietary Name | Vantin |
Package Description | 1 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-390-79) |
Product NDC | 55289-390 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefpodoxime proxetil |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19910829 |
Marketing Category Name | NDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | CEFPODOXIME PROXETIL |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |